Here we show that Peptide R-NIR750 specifically binds to CXCR4 overexpressing tumor cells in vitro and in vivo and discriminates the effect of Peptide R treatment on the development of lung metastases through fluorescence molecular tomography. This evidence concerns the gene CXCR4 and neoplasm.